Cenobamate: A comprehensive review

This publication has 86 references indexed in Scilit:

• Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy
  JAMA Neurology, 2026
• Using Cenobamate for managing idiopathic generalized epilepsy: A single‐center experience and systematic literature review
  Epilepsia Open, 2025
• Real‐world effectiveness and tolerability of cenobamate in drug‐resistant epilepsy: A retrospective analysis of the patients included into the Early Access Programs (EAP) in Germany, France, and United Kingdom
  Epilepsia Open, 2025
• Efficacy of add‐on Cenobamate treatment in refractory epilepsy due to Rasmussen's encephalitis
  Epilepsia Open, 2024
• Safety and Efficacy of Cenobamate for the Treatment of Focal Seizures in Older Patients: Post Hoc Analysis of a Phase III, Multicenter, Open-Label Study
  Drugs & Aging, 2024
• Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory Study
  CNS Drugs, 2024
• Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program
  Epilepsia Open, 2023
• A Phase 1 Clinical Study Evaluating the Effects of Cenobamate on the QT Interval
  Clinical Pharmacology in Drug Development, 2022
• Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs
  JAMA Neurology, 2018
• Mechanism of action of the anticonvulsant felbamate: Opposing effects on N‐methyl‐D‐aspartate and γ‐aminobutyric acid_A receptors
  Annals of Neurology, 1994